<DOC>
	<DOC>NCT02272322</DOC>
	<brief_summary>This observational study will evaluate treatment of symptomatic cystocele grade II-III with Cousin Biomesh and Allium Medical Endofast Reliant. Data about 100 patients will be collected. Follow-up till 3 years after the procedure. Primary endpoint is absence of recurrence.</brief_summary>
	<brief_title>Transvaginal Treatment of Symptomatic Cystocele Grade II-III</brief_title>
	<detailed_description />
	<mesh_term>Cystocele</mesh_term>
	<mesh_term>Hernia</mesh_term>
	<criteria>Patient is a woman Patient is between 40 and 90 years old Patient has to sign the informed consent form prior to the procedure Patient has to agree with the scheduled followup visits on month 1, month 6, year 1, year 2 and year 3 Patient has symptomatic anterior prolapse Recurrence cystocele Patient is pregnant Patient has a wish to become pregnant Patient is taking Plavix, Sintrom, Marcoumar, Marevan, Brilique, Efient, Ticlid, Xarelto, Eliquis or Pradaxa. If intake is stopped prior to procedure, patient is allowed to be included. Patient is taking LMWH in a dose of more than 40 mg/day Patient has a life expectancy &lt; 1 year Patient has a known connective tissue disease Patient has a history of surgery of the anterior vaginal wall or pelvis A scheduled hysterectomy during the indexprocedure</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Anterior prolapse</keyword>
</DOC>